Medicare Caps Copay for Insulin at $35 per Month
As most of you (and your Medicare patients) have undoubtedly noticed, Medicare has applied a $35 per month cap on copays for insulin prescriptions ($105 for a 3-month supply) for years 2023-2025. For 2026 and beyond, copays will be capped at the lesser of $35 or 25% of the negotiated price.
Section 11406 of the Inflation Reduction Act of 2022 implemented this cap for Medicare Part D and Medicare Advantage patients effective January 1, 2023, while Section 11407 requires implementation for Medicare B covered insulin as of July 1, 2023.
Plan Sponsors have a 90-day grace period to implement these copay caps and any excess copays calculated at adjudication must be refunded by the plan.
PAAS Tips:
- Diabetic Test Strip Authorized Distributors - July 18, 2024
- How to Safeguard Your Pharmacy from Fraudulent Electronic Prescriptions - July 10, 2024
- Commercial Claims Reimbursed through Embedded GoodRx® Discount Cards - June 21, 2024